Sunshine Biopharma Inc. financial data

Symbol
SBFM, SBFMW on Nasdaq
Industry
Pharmaceutical Preparations
Location
333 Las Olas Way, Cu4 Suite 433, Fort Lauderdale, FL
State of incorporation
CO
Fiscal year end
December 31
Former names
Mountain West Business Solutions, Inc (to 11/2/2009), mountain west business solutions,inc (to 10/19/2007), mountain state business solutions,inc (to 5/25/2007)
Latest financial report
10-K - Q4 2024 - Apr 1, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 470 % +2.91%
Quick Ratio 164 % +100%
Debt-to-equity 25.8 % -10.5%
Return On Equity -21.2 % -0.86%
Return On Assets -16.9 % -3.25%
Operating Margin -14.8 % +88.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.71M shares -97.3%
Common Stock, Shares, Outstanding 2.58M shares
Entity Public Float 22.6M USD +111%
Common Stock, Value, Issued 2.58K USD
Weighted Average Number of Shares Outstanding, Basic 702K shares
Weighted Average Number of Shares Outstanding, Diluted 702K shares +5372%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 33M USD +61.9%
Cost of Revenue 7.08M USD -45.9%
Research and Development Expense 934K USD -49.7%
General and Administrative Expense 16.5M USD +25.6%
Operating Income (Loss) -5.81M USD -21.5%
Nonoperating Income (Expense) 443K USD -34.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.37M USD -30.6%
Income Tax Expense (Benefit) -235K USD -159%
Net Income (Loss) Attributable to Parent -5.13M USD -13.9%
Earnings Per Share, Basic -7.32 USD/shares
Earnings Per Share, Diluted -2 USD/shares +74.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.7M USD -52.7%
Accounts Receivable, after Allowance for Credit Loss, Current 2.83K USD
Inventory, Net 11.3M USD +96.7%
Assets, Current 26M USD +4.32%
Property, Plant and Equipment, Net 546K USD +49.2%
Operating Lease, Right-of-Use Asset 936K USD +44.7%
Intangible Assets, Net (Excluding Goodwill) 3.02M USD +109%
Goodwill 0 USD
Assets 30.6M USD +11.8%
Accounts Payable, Current 5.54M USD +114%
Liabilities, Current 6.31M USD +13.7%
Operating Lease, Liability, Noncurrent 745K USD +38.2%
Liabilities 7.06M USD +15%
Accumulated Other Comprehensive Income (Loss), Net of Tax -830K USD -219%
Retained Earnings (Accumulated Deficit) -69M USD -8.03%
Stockholders' Equity Attributable to Parent 23.5M USD +10.8%
Liabilities and Equity 30.6M USD +11.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.19M USD -72.2%
Net Cash Provided by (Used in) Financing Activities 5.4M USD
Net Cash Provided by (Used in) Investing Activities -669K USD -357%
Common Stock, Shares Authorized 3B shares 0%
Common Stock, Shares, Issued 2.58M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.69M USD -40.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 6.97M USD +8.91%
Depreciation 64.6K USD +73.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.66M USD -67.7%
Property, Plant and Equipment, Gross 883K USD +58.8%
Operating Lease, Liability, Current 208K USD +75.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 198K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 208K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 196K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.46M USD +22.4%
Preferred Stock, Shares Authorized 30M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 178K USD
Additional Paid in Capital 93.4M USD +10.6%
Amortization of Intangible Assets 38.4K USD
Deferred Tax Assets, Net of Valuation Allowance 482K USD +173%
Interest Expense 145K USD +115%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares